Themes from the quarterly Quantitative Beta Research Summit
A close look at the Progressive Agenda, China’s deteriorating welcome mat in DC and US Tech IPOs.
Michael Cembalest analyzes the performance of over 6,700 domestic and international active equity managers, and discusses the challenges they face outperforming at a time of markets distorted by quantitative easing.
Incorporating Environmental, Social & Governance
An update from the front lines of the Trade War, with a focus on implications for investors
The S&P 500 could hit 10,000 by the mid-2030s
The food fight between the President and the Fed Chair could result in too much easing, and the expansion of valuations beyond sustainable levels. The other food fight: leveraged loan issuers vs buyers. Issuers are winning this fight hands down due.
Michael shares his thoughts on the US China trade war, Mexico tariffs and the US immigration policy.
A strategic framework for building a private credit portfolio
Michael discusses US-China trade war in context, the outlook for prescription drug price legislation, and an updated ideological scorecard for 2020 Presidential candidates.